• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

MS Sequencing: Part 1 – Mechanism of action of DMTs

November 3, 2016  

ECTRIMS 2016 SLIDE DECK

October 24, 2016  

Phase III results for siponimod in SPMS

September 28, 2016  

ECTRIMS DAILY REPORT – SATURDAY EDITION

September 17, 2016  

ECTRIMS DAILY REPORT – FRIDAY EDITION

September 16, 2016  

ECTRIMS DAILY REPORT – THURSDAY EDITION

September 15, 2016  

EMD Serono’s LAUNCH program – A model for academia/industry partnerships

September 7, 2016  

EDSS change an unreliable measure of progression

August 17, 2016  

Brain volume loss associated with cognitive decline in MS

July 27, 2016  

Relevance of assessing body weight in MS patients

June 8, 2016  
Previous
28
29
30
31
32
Next

Browse by Topic

  • MS (444)
  • CLINICAL CASES (22)
  • EAN 2026 (2)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Ofatumumab 2026 – update on real-world effectiveness posted on September 22, 2026
  • CLINICAL CASES IN NEUROLOGY – A YOUNG WOMAN WITH MILD EARLY MS posted on September 17, 2026
  • Highlights of EAN 2026 – Part 2 posted on July 9, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions